Zitter Health Insights Access Answered.

Rheumatoid Arthritis

Pharmacy & Therapeutics (P&T) Perspective

From this 120-minute simulated P&T Committee syndicated research product you will gain insights on:

  • How P&T members will manage the increasingly crowded RA space
  • What manufacturers will need to do in order to supplant one of the existing therapies
  • Where tofacitinib lies in the RA treatment paradigm
  • How much of a factor route of adminstration (ROA) is within RA
  • How contracting influences the committee’s formulary restrictions